Table 2.

Clinical and laboratory parameters of patients at enrollment and at the end of the 1-year follow-up

Variable	Normovolemic (n = 48)			Hypervolemic (n = 30)
	enrollment	1-year follow-up	p value	enrollment	1-year follow-up	p value
OH, L	−0.78±0.62	−0.74±0.75	0.749	1.17±1.13	1.49±1.46	0.112
eGFR, mL/min	44.4±13.6	48±16.1	0.024	43.4±15.4	38.8±16	<0.001
Uric acid, mg/dL	7.6±2.2	7.2±1.6	0.267	7.6±1.7	7.4±2	0.412
Glucose, mg/dL	128.6±44.4	130.2±58.8	0.784	145±80	145±83.8	0.993
HbA1c, %	6.7±1.1	6.6±1.2	0.246	7.3±1.8	7.1±1.7	0.391
Urine protein level, mg/g	954.6±2345.2	653.3±811.5	0.544	1,339±1889	1,592±2384.8	0.821
LDL, mg/dL	143.4±42.8	132±49	0.322	129±42.1	126.5±32.5	0.468
Triglycerides, mg/dL	206.6±90.8	222.1±116.1	0.578	215.4±101.5	194.7±82.1	0.424
Systolic BP, mm Hg	130.8±17.3	134.5±16.5	0.130	132±13	139.3±17.2	0.033
Diastolic BP, mm Hg	76.8±7.7	81.2±8.4	0.004	79±11.2	79±11.8	1.000

Data are expressed as means ± SD. See Table 1 for abbreviations.